This site is intended for healthcare professionals outside the US
This is an international product site for Sandostatin® LAR® and is intended for Health Care Professionals outside the U.S.
SANDOSTATIN® LAR® (octreotide) is approved for use in 92 countries around the world.
The information on site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country. Please contact your local representative for local prescribing information via www.NovartisOncology.com/contactus.
IMPORTANT: The imformation on this website is based on the Sandostatin LAR EU SmPC
